Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - methyldopa -

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - methyldopa -

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - methyldopa -

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - methyldopa sesquihydrate 125mg (as the sesquihydrate. 142.86 including overage.) - film coated tablet - 125 mg - active: methyldopa sesquihydrate 125mg (as the sesquihydrate. 142.86 including overage.) excipient: carmellose magnesium stearate microcrystalline cellulose opaspray povidone starch

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - methyldopa sesquihydrate 250mg (as the sesquihydrate. 285.72mg including overage.) - film coated tablet - 250 mg - active: methyldopa sesquihydrate 250mg (as the sesquihydrate. 285.72mg including overage.) excipient: carmellose magnesium stearate microcrystalline cellulose opaspray povidone starch

New Zealand - English - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - methyldopa sesquihydrate 500mg (as the sesquihydrate. 571mg including overage.) - film coated tablet - 500 mg - active: methyldopa sesquihydrate 500mg (as the sesquihydrate. 571mg including overage.) excipient: carmellose magnesium stearate microcrystalline cellulose opaspray povidone starch

New Zealand - English - Medsafe (Medicines Safety Authority)

origen pharmaceuticals limited - methyldopa - tablet - 125mg, 250mg, 500mg - active: methyldopa

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - methyldopa sesquihydrate -

United States - English - NLM (National Library of Medicine)

rebel distributors corp - methyldopa (unii: 56lh93261y) (methyldopa - unii:56lh93261y) - hypertension. methyldopa is contraindicated in patients: - with active hepatic disease, such as acute hepatitis and active cirrhosis. - with liver disorders previously associated with methyldopa therapy (see warnings ). - with hypersensitivity to any component of this product. - on therapy with monoamine oxidase (mao) inhibitors.

Kenya - English - Pharmacy and Poisons Board

medopharm c/o medox pharmaceuticals ltd p.o.box 52771-00200 nairobi - methyldopa - coated tablet - 250 mg - antihypertensives: methyldopa